BRCA2改变与前列腺癌导管内及筛状组织学类型的关联
本研究通过病例对照设计,将58例gBRCA2携带者的原发前列腺肿瘤按Gleason分级分组和标本类型1:2匹配116例非携带者,由两位对gBRCA2状态盲法的泌尿病理专家判定IDC和CRIB形态。结果显示gBRCA2突变与IDC或CRIB组织学无显著关联,但双等位BRCA2缺失与IDC(OR 4.3, 95%CI 1.1-16.2)和CRIB(OR 5.6, 95%CI 1.7-19.3)独立相关。
要点
- gBRCA2携带者与非携带者的IDC(36% vs 50%, p=0.085)和CRIB(53% vs 43%, p=0.197)患病率无显著差异。
- 双等位BRCA2缺失与原发前列腺肿瘤IDC(OR 4.3, 95%CI 1.1-16.2)和CRIB(OR 5.6, 95%CI 1.7-19.3)独立相关。
- PTEN纯合缺失与IDC独立相关(OR 5.2, 95%CI 2.1-13.1)。
核心结论
- gBRCA2突变与前列腺癌IDC或CRIB组织学无显著关联。
- 原发前列腺肿瘤中的双等位BRCA2缺失与IDC和CRIB两种变异形态独立相关。
研究设计与样本
- 病例对照研究,58例gBRCA2携带者的原发前列腺肿瘤按Gleason分级分组和标本类型1:2匹配116例非携带者。
- 由两位对gBRCA2状态盲法的泌尿病理专家判定IDC和CRIB形态。
- 采用FISH和NGS检测BRCA2改变、PTEN缺失和TMPRSS2-ERG融合。
主要发现
- gBRCA2携带者与非携带者的IDC患病率分别为36%和50%(p=0.085),无显著差异。
- gBRCA2携带者与非携带者的CRIB患病率分别为53%和43%(p=0.197),无显著差异。
- IDC组织学与双等位BRCA2改变(OR 4.3, 95%CI 1.1-16.2)和PTEN纯合缺失(OR 5.2, 95%CI 2.1-13.1)独立相关。
- CRIB形态与双等位BRCA2改变独立相关(OR 5.6, 95%CI 1.7-19.3)。
临床怎么用
- 对于原发前列腺肿瘤伴有IDC或CRIB形态的患者,可考虑检测肿瘤BRCA2双等位缺失以辅助风险评估。
- gBRCA2突变状态本身与IDC/CRIB形态无关,不应仅凭IDC形态决定gBRCA2基因检测。
局限性
- 样本量较小(58例携带者),可能影响统计效能。
- 回顾性病例对照设计,存在选择偏倚可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraductal (IDC) and cribriform (CRIB) histologies in prostate cancer have been associated with germline BRCA2 (gBRCA2) mutations in small retrospective series, leading to the recommendation of genetic testing for patients with IDC in the primary tumour. PATIENTS AND METHODS: To examine the association of gBRCA2 mutations and other tumour molecular features with IDC and/or cribriform (CRIB) histologies, we conducted a case-control study in which primary prostate tumours from 58 gBRCA2 carriers were matched (1:2) by Gleason Grade Group and specimen type to 116 non-carriers. Presence/absence of IDC and CRIB morphologies was established by two expert uropathologists blinded to gBRCA2 status. Fluorescent in-situ hybridization (FISH) and next-generation sequencing (NGS) were used to detect BRCA2 alterations, PTEN deletions and TMPRSS2-ERG fusions. Chi-squared tests were used to compare the frequency of IDC and CRIB in gBRCA2 carriers and controls and to assess associations with other variables. Logistic regression models were constructed to identify independent factors associated with both histology patterns. RESULTS: No significant differences between gBRCA2 carriers and non-carriers were observed in the prevalence of IDC (36% gBRCA2 versus 50% non-carriers, p = 0.085) or CRIB (53% gBRCA2 versus 43% non-carriers p = 0.197) patterns. However, IDC histology was independently associated with bi-allelic BRCA2 alterations (OR 4.3, 95%CI 1.1-16.2) and PTEN homozygous loss (OR 5.2, 95%CI 2.1-13.1). CRIB morphology was also independently associated with bi-allelic BRCA2 alterations (OR 5.6, 95%CI 1.7-19.3). CONCLUSIONS: While we found no association between gBRCA2 mutations and IDC or CRIB histologies, bi-allelic BRCA2 loss in primary prostate tumours was significantly associated with both variant morphologies, independently of other clinical-pathologic factors.
引用
- Lozano R, Salles DC, Sandhu S, et al. Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer. Eur J Cancer. 2021. PMID: 33626496. doi:10.1016/j.ejca.2021.01.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。